Evgen Pharma plc announced that Toni Hänninen has been appointed as permanent Chief Financial Officer (CFO). Toni Hänninen was appointed interim CFO in September 2023. He is now taking on the CFO role on a permanent basis.

His appointment is effective from 1 January 2024. Toni was previously CFO at Faron Pharmaceuticals Ltd, an AIM and Nasdaq First North listed clinical stage biopharmaceutical company based in the Finland and the US, developing novel treatments for medical conditions with significant unmet needs. He holds over 20 years of experience in business development and senior finance roles in both public and private companies, working in mature and emerging markets particularly in Europe and the USA where he has accomplished successful fundraises, transactions and fiscal management in the sector.

Toni has an MBA from the Helsinki School of Economics (now Aalto University).